within Pharmacolibrary.Drugs.ATC.D;

model D10AD51
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0005,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D10AD51</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tretinoin, often marketed as all-trans-retinoic acid, is a derivative of vitamin A used primarily in dermatology for the topical treatment of acne vulgaris and various skin conditions. In combination products (ATC code D10AD51), tretinoin may be formulated with other agents, such as antibiotics or antiseptics, to enhance efficacy. These combination therapies are used for moderate-to-severe acne and are approved for topical use in many countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for topical combination tretinoin use in healthy adults, as there are no direct published sources of population pharmacokinetics for D10AD51 formulations.</p><h4>References</h4><ol><li><p>Fitton, A, &amp; Goa, KL (1991). Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. <i>Drugs</i> 41(5) 780–798. DOI:<a href=\"https://doi.org/10.2165/00003495-199141050-00007\">10.2165/00003495-199141050-00007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1712709/\">https://pubmed.ncbi.nlm.nih.gov/1712709</a></p></li><li><p>Noble, S, &amp; Wagstaff, AJ (1995). Tretinoin. A review of its pharmacological properties and clinical efficacy in the topical treatment of photodamaged skin. <i>Drugs &amp; aging</i> 6(6) 479–496. DOI:<a href=\"https://doi.org/10.2165/00002512-199506060-00008\">10.2165/00002512-199506060-00008</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7663068/\">https://pubmed.ncbi.nlm.nih.gov/7663068</a></p></li><li><p>van Hoogdalem, EJ (1998). Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. <i>Journal of the European Academy of Dermatology and Venereology : JEADV</i> 11 Suppl 1 S13–S29. DOI:<a href=\"https://doi.org/10.1111/j.1468-3083.1998.tb00902.x\">10.1111/j.1468-3083.1998.tb00902.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9891904/\">https://pubmed.ncbi.nlm.nih.gov/9891904</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D10AD51;
